Insider · CIK 0002026040
Therapeutics ApS Alteral
Files at NORD (Nordicus Partners Corp). First filing -, latest -.
In brief
Therapeutics ApS Alteral files SEC Form 4 as 10% owner at NORD (Nordicus Partners Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Therapeutics ApS Alteral has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 12, 2024 | NORD Nordicus Partners Corp | JOther Common stock | +4,030,903 | - | - | 5,296,131 | Dec 10, 2024 |
Questions about Therapeutics ApS Alteral
Answered from the filings on this page, as of the latest one.
Is Therapeutics ApS Alteral buying or selling?
Therapeutics ApS Alteral has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Therapeutics ApS Alteral's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Therapeutics ApS Alteral has 0.
Where does Therapeutics ApS Alteral file Form 4?
Therapeutics ApS Alteral has filed Form 4 at NORD (Nordicus Partners Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.